What is MOgene?
MOgene, established in 2004, is a specialized provider of precise genomic solutions catering to research institutions, biotechnology firms, pharmaceutical companies, and government agencies. The company offers a comprehensive suite of services, including biopharma genomic services, agritech genomic services, microbiome analysis, and advanced bioinformatics. MOgene's consultative approach emphasizes expert guidance throughout project lifecycles, ensuring high-quality outcomes for projects of all scales. Their commitment lies in advancing agriculture and medicine through cutting-edge genomic technologies.
How much funding has MOgene raised?
MOgene has raised a total of $373K across 2 funding rounds:
Debt
$150K
Debt
$223K
Debt (2020): $150K with participation from PPP
Debt (2021): $223K led by PPP
Key Investors in MOgene
PPP
Public-Private Partnership
PPP
Public-Private Partnership
PPP
Public-Private Partnership
What's next for MOgene?
With a substantial large-scale late-stage funding context, MOgene is poised for significant growth and strategic development. This latest round of financing is expected to fuel further innovation in their genomic service offerings, potentially expanding their market reach into new therapeutic areas or agricultural applications. The company's focus on precision and consultative expertise positions it well to capitalize on the increasing demand for advanced genomic insights in both research and commercial sectors.
See full MOgene company page
